KLRS
Kalaris Therapeutics, Inc.
2.90$
-4.9%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 100.0% | 91.3% | 97.4% | 88.4% | 100.0% | 100.0% | 100.0% | 97.6% | |
| 98.6% | 43.8% | 33.1% | 70.4% | 78.5% | 95.1% | 99.8% | 80.5% | |
| 98.6% | 90.4% | 96.1% | 86.6% | 78.5% | 95.1% | 99.8% | 96.9% | |
| 1.2% | 0.4% | 0.1% | 0.0% | – | – | – | – | |
| 14.8% | 12.8% | 4.8% | 21.4% | 876.4% | 1,450.6% | 4.4% | 35.3% | |
| 14.8% | 6.5% | 3.3% | 13.2% | 146.0% | 118.3% | 4.4% | 8.0% | |
| – | 2.2% | 0.9% | 2.3% | – | – | – | 0.3% | |
| 0.6% | 0.5% | 0.3% | 2.9% | 70.8% | 70.9% | 0.2% | 1.1% | |
| – | – | – | – | 83.4% | – | – | – | |
| 85.2% | 87.2% | 95.2% | 78.6% | -776.4% | -1,350.6% | 95.6% | 64.7% | |
| -124.3% | -39.7% | -33.7% | -103.7% | -838.5% | -1,422.0% | -603.1% | -131.4% | |
| 11.2% | 2.0% | 0.3% | 1.0% | 85.5% | 135.7% | 4.2% | 12.5% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.